JNJ

NYSE

JOHNSON & JOHNSON

Health Care, Pharmaceuticals

$259.24

close 7 Aug 2026

+49.14%

52-week change

$624.74B

market cap

$171.81

$274.90

52-week range

Expected price

$180.61 – $220.75

Current price

$259.24

Signal

Could be overvalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)30.11x

P/S (TTM)6.38x

P/B7.35x

EV/EBITDA (TTM)19.31x

FCF yield (TTM)3.56%

PEG (TTM, GAAP)1.68

Context

P/E, own 5-year average21.77x

P/E, sector median29.65x*

Price at 5-year median P/E$203.57*

Indicated dividend yield2.07%

Forward — analyst consensus

Forward P/E (FY2026)23.46x*

Forward P/E (FY2027)21.06x

Forward PEG2.07*

Consensus EPS FY2026 (4 analysts)$11.05

EPS growth (FY2026→FY2027)11.35%

Revenue growth (FY2026)7.36%

Street view

Price target (mean)$272.50*

Target upside5.11%

Ratings (buy / hold / sell)16 / 6 / 1

FY2026 EPS revisions, 30d (up / down)21 / 0

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 28 Jun 2026, filed 23 Jul 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR -0.49%10Y CAGR +2.03%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$259.24

Cash & equivalents$20.42B

Total debt$49.04B

Shares outstanding2.41B

Result

DCF price per share$124.46

Current price$259.24

Margin of safety-51.99%

PV of years 1–10$145.74B

PV of terminal value$182.81B

Equity value$299.94B

Market-implied growth+8.33%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$22.14B	$22.03B	$21.92B	$21.81B	$21.70B	$21.60B	$21.49B	$21.39B	$21.28B	$21.18B	$394.68B
PV	$20.50B	$18.88B	$17.40B	$16.03B	$14.77B	$13.61B	$12.54B	$11.55B	$10.65B	$9.81B	$182.81B

period to 28 Jun 2026, filed 23 Jul 2026, close 7 Aug 2026